These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18675761)

  • 1. Current status and future direction of the molecular modeling industry.
    Richon AB
    Drug Discov Today; 2008 Aug; 13(15-16):665-9. PubMed ID: 18675761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An early history of the molecular modeling industry.
    Richon AB
    Drug Discov Today; 2008 Aug; 13(15-16):659-64. PubMed ID: 18675760
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemistry plans a structural overhaul.
    Russo E
    Nature; 2002 Sep; 419(6903):4-7. PubMed ID: 12226620
    [No Abstract]   [Full Text] [Related]  

  • 4. Differentiating genomics companies.
    James R
    Nat Biotechnol; 2000 Feb; 18(2):153-5. PubMed ID: 10657119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotech round the world: focus on Canada.
    Biotechnol J; 2008 Jul; 3(7):848-51. PubMed ID: 18624341
    [No Abstract]   [Full Text] [Related]  

  • 6. Grid computing in large pharmaceutical molecular modeling.
    Claus BL; Johnson SR
    Drug Discov Today; 2008 Jul; 13(13-14):578-83. PubMed ID: 18598912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of data mining approaches to drug delivery.
    Ekins S; Shimada J; Chang C
    Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1409-30. PubMed ID: 17081647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics in the pharmaceutical industry.
    Lyall A
    Trends Biotechnol; 1996 Aug; 14(8):308-12. PubMed ID: 8987464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell biology gets plugged in.
    Gershon D
    Nature; 2002 Jun; 417(6892):6. PubMed ID: 12087361
    [No Abstract]   [Full Text] [Related]  

  • 10. Using computational modeling to drive the development of targeted therapeutics.
    Nielsen UB; Schoeberl B
    IDrugs; 2005 Oct; 8(10):822-6. PubMed ID: 16254802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genzyme Molecular Oncology and Silico Insights to comarket genomics technologies.
    Expert Rev Mol Diagn; 2002 Jul; 2(4):295-6. PubMed ID: 12138487
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemistry: power play.
    Borrell B
    Nature; 2008 Jan; 451(7176):240-3. PubMed ID: 18202619
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiscale modeling in drug discovery and development: future opportunities and present challenges.
    Vicini P
    Clin Pharmacol Ther; 2010 Jul; 88(1):126-9. PubMed ID: 20520608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computerized role models.
    Triendl R
    Nature; 2002 Jun; 417(6892):7. PubMed ID: 12087362
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic development: a victim of market forces?
    Tillotson GS
    IDrugs; 2008 May; 11(5):340-6. PubMed ID: 18465675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data mining.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT35-6. PubMed ID: 11221713
    [No Abstract]   [Full Text] [Related]  

  • 17. Does the European pharmaceutical industry have a future?
    McKillop T
    Circulation; 2006 Feb; 113(5):f19-20. PubMed ID: 16468149
    [No Abstract]   [Full Text] [Related]  

  • 18. Buying into the knowledge game.
    Buckingham S
    Nature; 2004 Apr; 428(6984):775. PubMed ID: 15085140
    [No Abstract]   [Full Text] [Related]  

  • 19. Web alert. The management of chemical and biological information.
    Cavalla D
    Curr Opin Drug Discov Devel; 2001 May; 4(3):271-2. PubMed ID: 11560057
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmaceutical industry in the Arab world: challenges, controversies, and future outlook.
    Kandil O
    Drug Discov Today; 2004 Jul; 9(13):543-5. PubMed ID: 15203084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.